Ditch the Diagnostic Delays: Patients With PAH Tell Their Stories
A CHEST 2024 CME Lunch Symposium
Pulmonary arterial hypertension (PAH) is a progressive disease, and in advanced stages, patients experience worsening of symptoms and significantly reduced quality of life. While early diagnosis is critical to limiting progression of disease, patients can wait years for a clinical diagnosis. This live symposium will introduce pulmonologists to multiple patients and their experiences with delayed diagnosis and treatment.
Sunday, October 6
12 pm - 1:15 pm ET
Omni Boston Hotel, Momentum EFG
Please RSVP to let us know if you'll be attending.
The American College of Chest Physicians is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CHEST will provide AMA PRA Category 1 Credit™ and American Board of Internal Medicine MOC credits for participants.
This activity is supported by an educational grant from Merck, Inc., and Actelion Pharmaceuticals US, a Janssen Pharmaceutical Company of Johnson & Johnson.